SRH Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-145
Closed -$9.28K – 275
2026
Q2
$9.28K Hold
145
– – ﹤0.01% 225
2026
Q1
$10.3K Hold
145
– – ﹤0.01% 216
2025
Q4
$11.9K Hold
145
– – ﹤0.01% 208
2025
Q3
$10.9K Hold
145
– – ﹤0.01% 208
2025
Q2
$10.7K Hold
145
– – ﹤0.01% 206
2025
Q1
$11.7K Hold
145
– – ﹤0.01% 202
2024
Q4
$11.3K Hold
145
– – ﹤0.01% 209
2024
Q3
$13.6K Hold
145
– – ﹤0.01% 198
2024
Q2
$11.3K Hold
145
– – ﹤0.01% 207
2024
Q1
$13.2K Hold
145
– – ﹤0.01% 199
2023
Q4
$11.2K Hold
145
– – ﹤0.01% 202
2023
Q3
$9.9K Sell
145
-13
-8% -$946 ﹤0.01% 199
2023
Q2
$13K Hold
158
– – 0.01% 184
2023
Q1
$13K Buy
+158
New +$11.3K 0.01% 184

Other funds holding GEHC

SRH Advisors's GEHC Position: Q3 2026 in Review

SRH Advisors sold out of GE HealthCare (GEHC) in Q3 2026, closing a stake of 145 shares — an estimated $9.28K sold.

SRH Advisors first reported a position in GEHC in Q1 2023 and held it in 14 quarters. The position peaked at $13.6K in Q3 2024. 287 funds tracked by Wall St. Rank hold GEHC as of Q3 2026.

  • SRH Advisors reported no remaining GE HealthCare position as of Q3 2026 after selling out during the quarter.
  • SRH Advisors sold 145 GE HealthCare shares in Q3 2026, an estimated $9.28K.
  • SRH Advisors first reported a position in GE HealthCare in Q1 2023 and held it in 14 quarters.
  • SRH Advisors's GE HealthCare position peaked at $13.6K in Q3 2024.
  • 287 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2026.

Based on SRH Advisors's 13F filing for Q3 2026, filed 22 Oct 2026.